SPECIAL ARTICLES


Acesso aberto Revisado por pares

0

Visualização

Does mismatch negativity have utility for NMDA receptor drug development in depression?

Nicholas Murphy1,2,3, Marijn Lijffijt1,2, Nithya Ramakrishnan1,2, Bylinda Vo-Le1,2, Brittany Vo-Le1,2, Sidra Iqbal1,2, Tabish Iqbal1,2, Brittany O'Brien1,2, Mark A. Smith4,5, Alan C. Swann1,2, Sanjay J. Mathew1,2,3

DOI: 10.1590/1516-4446-2020-1685

Epub: 5 de Abril de 2021

Vol.44 Issue 1/2022:

1Menninger Department of Psychiatry and Behavioral Sciences, Baylor College of Medicine, Houston, TX, USA
2Michael E. DeBakey VA Medical Center, Houston, TX, USA
3The Menninger Clinic, Houston, TX, USA
4VistaGen Therapeutics, Inc., South San Francisco, CA, USA
5Medical College of Georgia, Augusta, GA, USA

Corresponding author

Sanjay J. Mathew, Menninger Department of Psychiatry and Behavioral Sciences, Baylor College of Medicine, 7515 Main St., Houston, TX, 77030, USA. E-mail: sjmathew@bcm.edu


© 2026 All rights reserved